Cambridge Investment Research Advisors’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio HTEC Stock Details HTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,564	Closed	-$219K	–	3110
2022 Q2	$219K	Buy	7,564 +193	+3%	+$5.97K	﹤0.01%	2651
2022 Q1	$268K	Buy	+7,371	New	+$273K	﹤0.01%	2643

Other funds holding HTEC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cambridge Investment Research Advisors's HTEC Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q3 2022, closing a stake of 7,564 shares — an estimated $219K sold.

Cambridge Investment Research Advisors first reported a position in HTEC in Q1 2022 and held it in 2 quarters. The position peaked at $268K in Q1 2022. 33 funds tracked by Wall St. Rank hold HTEC as of Q3 2022.

Cambridge Investment Research Advisors reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q3 2022 after selling out during the quarter.
Cambridge Investment Research Advisors sold 7,564 ROBO Global Healthcare Technology and Innovation ETF shares in Q3 2022, an estimated $219K.
Cambridge Investment Research Advisors first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q1 2022 and held it in 2 quarters.
Cambridge Investment Research Advisors's ROBO Global Healthcare Technology and Innovation ETF position peaked at $268K in Q1 2022.
33 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.